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Abstract
Background: Many of the 28 million deaths from noncommunicable diseases
(NCDs) in low‐ and middle‐income countries each year could be prevented through
early detection and intervention. The introduction of screening for NCDs in commu-
nity pharmacies (CPs) in Ghana could enhance access to early detection.
Methods: We surveyed clients in three districts in suburban Ghana to assess per-
ceived need for screening, willingness to be screened in CPs, and willingness to receive
NCD health promotion information through text messages (NCD m‐Health). We per-
formed regression analysis to identify predictors of NCD m‐Health acceptability.
Results: We interviewed 330 clients in six CPs, 134 (42.3%) of whom were females.
The median age was 34 years (interquartile range, 27‐43). Fifty‐four (16.4%) had no
formal education. Although most respondents knew obesity (74.9%), smoking
(81.9%), and excessive dietary salt (91.7%) were risk factors for NCDs, only 27.0%
knew family history carried similar risk. Most respondents, 61.6% and 70.6%, respec-
tively, had not had their weight and blood pressure (BP) checked for more than
12 months. These included about a third of respondents who were known hyperten-
sives. Similarly, 71.3% of 80 participants with a family history of hypertension had not
had their BPs checked. Screening for NCDs in CPs and the sending of NCD m‐Health
messages was deemed acceptable to 98.5% and 83.1% of the participants, respec-
tively. Formal education beyond junior high school (Grade 9) was the strongest inde-
pendent predictor of NCD m‐Health acceptance (OR = 4.77; 95% CI, 1.72‐13.18; P
value < 0.01). One hundred and twenty‐five (39.4%) participants indicated they would
consider unsolicited NCD m‐Health messages an invasion of their privacy.
Conclusion: An urgent need exists to promote access to NCD screening in these
communities. Its introduction into CPs is acceptable to nearly all the clients surveyed.
The introduction of NCD m‐Health as an accompaniment requires consideration for
the privacy of clients.
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1 | BACKGROUND
Noncommunicable diseases (NCDs) kill 38 million people each year,
with almost three quarters of these deaths occurring in low‐ and
middle‐income countries (LMICs). 1 The catastrophic cost associated
with long‐term treatment entrenches poverty and undermines produc-
tivity. It is predicted that by 2020, NCDs will cause seven out of every
10 deaths in these countries.2 Without purposeful implementation of
a global plan to tackle NCDs in LMICs, Sustainable Development Goal
(SDG) 3, which targets reduction in premature NCD mortality by a
third by 2030, is not likely to be achieved.3-6
In 2010, hypertension occurred to 31.1% of the world's adult pop-
ulation, 28.5% (27.3%‐29.7%) in high‐income countries and 31.5%
(30.2%‐32.9%) in LMICs.7 Studies in Ghana and Nigeria in West Africa
and Lesotho and rural Zulu in South Africa have found hypertension
prevalence rates of between 15% and 50%.8-10 There is the need to
identify simple, low‐cost interventions that will address the high
burden of hypertension in these countries in sub‐Saharan Africa
(SSA).1 As a major NCD, it is estimated that tens of millions of hyper-
tension‐related deaths could be prevented through BP checking and
early care.11
The four main types of NCDs are cardiovascular diseases (such as
heart attacks and stroke), cancer, chronic respiratory diseases (such as
chronic obstructed pulmonary disease and asthma), and diabetes.
These NCDs share smoking, excessive alcohol, lack of physical activity,
and poor eating habits as common modifiable risk factors.12,13 The
majority of NCDs develop slowly. This makes screening (where possi-
ble) an important intervention in their control, especially in LMICs
where access to curative services is limited.
The primary health care (PHC) systems of most countries in SSA
evolved in response to the impact of communicable diseases. The
exact form of a health system in SSA that adequately responds to
the epidemic of NCDs remains a subject of continuing research. An
important agenda in this regard is identifying the appropriate platform
for expanding access to screening and primary care for high‐risk indi-
viduals, while appropriately managing treatment options in resource‐
limited settings.14-16
One of the most decentralized structures within the health system
of many countries in SSA is the operation of community pharmacies
(CPs). Community pharmacies are found to operate in settings where
other health services such as clinics and hospitals are not available.17
For a variety of reasons, community members often prefer to make
CPs their first port of call for disease prevention advice and medicines
to initiate treatment.18 The potential for the use of CPs to expand
opportunities for NCD screening is gradually being appreciated.19,20
In most of SSA, however, this is yet to be formalized and systemati-
cally deployed as an intervention in NCD prevention. A systematic
review of the evidence on the feasibility and acceptability of using
CPs to screen for major diseases concluded that screening for some
diseases in CPs was generally feasible.21 Questions remain about
acceptability in different sociocultural settings, cost effectiveness,
and the nature and form of follow‐up services.
In Ghana, NCDs are now recognized as major causes of significant
illness and deaths. The evidence base for community‐based interven-
tions is weak because NCDs have, until recently, not been a part of
PHC in the country.22-24 The health system in Ghana is in acute need
of evidence‐based interventions that will guide expanded access to
NCD screening, early detection, and management.25,26 The accessibil-
ity of CPs and their widespread use as a port of first contact makes
them potentially ideal for NCD screening and related primary care
services. The regulated nature of community pharmacy practice in
Ghana implies that the integration of NCD screening in CPs can be
formalized and supervised. Evidence on the potential role of m‐Health
in providing low‐cost follow‐up services is also emerging.27
As part of an intended program to introduce screening for NCDs
in CPs in three districts in southeastern Ghana, we conducted a survey
among clients of CPs in these districts to assess acceptability and to
identify other possible threats to effective implementation.
2 | METHODS
2.1 | Study design and site
The study was conducted in CPs in the Asuogyaman, Lower Manya
Krobo, and Yilo Krobo districts of the Eastern region of Ghana. The
three districts have a combined population of about 400 000. Most
inhabitants live in rural settlements. The main occupations are subsis-
tence farming and fishing. The most common ethnic groups are the
Ga‐Adangbes and Akwamus. The respective district capitals,
Akosombo, Odumase, and Somanya, are all suburban. Each district
has at least either a district hospital (Asuogyaman, Lower Manya
Krobo) or a polyclinic (Yilo Krobo) that are staffed by a medical officer
and where comprehensive services, including special clinics and
surgeries, are performed.
The public health services in the three districts are managed by
the District (and Municipal) Health Management Teams. The approach
to the delivery of public health services is based on the PHC concept,
with emphasis on the control of communicable diseases and provision
of maternal and child health services. The delivery of adult health ser-
vices including NCD screening remain largely at the level of health
centers and hospitals at subdistrict and district levels, respectively.
The most decentralized form of health service provision are privately
owned CPs and over‐the‐counter–medicine shops. There is a total of
nine CPs in the three districts.
Over a 6‐week period, adult (aged ≥18 y) clients at six selected
CPs in the three districts were interviewed using a questionnaire that
inquired into sociodemographic background, personal and family his-
tory of hypertension and diabetes, access to screening for hyperten-
sion and diabetes, and willingness to avail oneself of CP‐based
screening services and to receive NCD‐related health promotion mes-
sages via text messaging (m‐Health). The input of the owners of CPs,
experienced local public health practitioners, and program officers of
community‐based health programs were sought to finalize the
questionnaire.
The most highly patronized CPs in the three districts were
selected, and the owners were approached for permission to interview
clients. At the time of the study, none of the selected CPs was offering
NCD screening services. All adult clients reporting to the CPs during
the day were targeted to be interviewed. The interviews were
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conducted by trained research assistants and in dialects that clients
were comfortable to speak in. Most of the questions on the question-
naire were close ended.
The data were entered into a computer using a platform created
in Microsoft Access 2013. Double data entry was used to ensure
accuracy. Data were then exported into Stata (version 12, College
Station, Texas) for analysis. Sociodemographic variables were analyzed
descriptively using chi‐square and means. Proportions and percent-
ages were computed based on the number of respondents who agreed
to respond that specific question. Willingness to be screened and to
receive m‐Health messaging via text were analyzed using logistic
regression. We included in the multivariate logistic regression model
variables that were significant in bivariate analysis at a P value of less
than 0.05. The final model was obtained using backward elimination
procedures. The results of regression analysis are presented here as
odds ratios (OR) with 95% confidence intervals (CI). All P values are
derived from chi‐square analysis except in instances when contin-
gency tables contain numbers that are less than five. In such instances,
Fisher's exact estimates are reported.
2.2 | Sample size
We planned to enroll 401 respondents on the basis that it will afford
an estimation of the proportion of clients willing to be screened for
NCD within a margin of error of 3.8% at 95% confidence level, assum-
ing 80% of clients will consider it acceptable. The predicted level of
acceptability was based on the finding of an acceptance level of 70%
in a study in Ghana where actual testing was performed.27 The six
selected CPs see about 12 000 clients in a year. The target sample size
was not achieved due to logistical constraints (see below).
2.3 | Ethical approval
The protocol for the study was reviewed and approved by the Institu-
tional Review Board of the Ensign College of Public Health, Kpong,
Ghana. Individual informed consent was obtained from each partici-
pant prior to the start of interview. The request to participate in the
survey was made only after clients had been served at the CPs and
were about to exit. No information that identified individual clients
was obtained.
3 | RESULTS
Overall, 352 clients were approached in six CPs over a 6‐week period
between March and May 2016. Out of this number, 330 (93.5%)
agreed to be interviewed. The main reason given by clients who
refused to participate was time constraint. Interviewed clients
consisted of 134 (42.3%) females. The median age was 34 (interquar-
tile range, 27‐43) years. The majority were Christians, 292 (89.9%).
Just about half, 148 (44.89%) were married. Most of the clients
(169, 51.2%) had formal education beyond junior high school, while
54 (16.4%) had no formal education. About half of the clients (160,
48.5%) belonged to the indigenous ethnic group Ga‐Adangbe. Most
respondents (181, 55.5%) lived more than an hour's walking distance
to the pharmacy at which they were interviewed; only 43 (13.2%)
lived within 30‐minute walking distance. About a quarter, 62 (22.6%)
of clients were unemployed at the time of the interview (Table 1).
3.1 | Awareness of risk factors and willingness to be
screened for NCDs
Obesity, smoking, and excess dietary salt were known to 245 (74.9%),
266 (81.9%), and 299 (91.7%) of clients, respectively, as risk factors for
developing hypertension and diabetes. The fact that family history
was a risk factor for these diseases was much less known (88, ie,
27.0%). Only 112 (35.1%) clients knew their weight at the time of
the interview. The last time 197 (61.6%) of the clients had a weight
check was over 12 months ago. Similarly, only 67 (20.8%) had an idea
about what their usual blood pressure (BP) level was. For 203 (70.6%)
respondents, the last time they had their BP checked was over
12 months ago (Table 2).
Nearly all, 322 (98.5%) and 312 (95.7%) clients, agreed with the
proposal to have BP measurement and urine testing for sugar intro-
duced into CPs. Over half of the respondents, 184 (55.8%) and 187
(56.7%), thought that the provision of BP and urine screening services
at CPs should be free of charge. Of those who thought the services
should be performed for a fee, the mean costs suggested were GHC
1.29 and GHC 4.48 (equivalent of USD 0.33 and USD 1.13) for BP
and urine screening, respectively. Forty‐four (13.5%) also indicated
they had close blood relations who had diabetes. Only 46 (13.9%)
respondents indicated they were current or former tobacco smokers.
3.2 | Weight and BP check for high‐risk clients
Thirty‐four (10.5%) clients indicated they were hypertensive. Out of
this number, however, about a third, 11 (32.3%) and 12 (35.3%), had
not had either their weight or BP checked for more than 12 months.
Eighty‐two clients (25.2%) also indicated they had blood relations
who were hypertensive. Out of this number, 51 (62.2%) involved
either or both parents. For more than 12 months prior to the survey,
47 (57.5%) and 58 (71.3%) of clients with a family history of hyperten-
sion had not had either their weight or BP checked. More than half, 67
(67.0%) and 41 (60.4%), of clients aged 40 years or more could neither
tell what their usual BP levels were nor the last time they had it
checked. Clients who were older than 50 years of age were more likely
to know the usual BP levels than those ages less than 30 years
(chi‐square test P value = 0.04). There was, however, no such statisti-
cally significant association between older age (>50 y) and BP
checking (chi‐square test P value = 0.22).
3.3 | Access to information technology and social
media
Nearly all clients (321, 97.3%) had access to a mobile phone. The pro-
portionwith access to other forms of information technology and social
media were as follows: Text messaging, 249 (75.5%); WhatsApp, 169
(51.2%); E‐mail, 108 (32.7%); and Facebook, 107 (32.4%). Two hundred
and sixty‐nine (83.3%) clients agreed to receive health promotional
messages via their mobile phones (NCD m‐Health). Their most pre-
ferred modes of messaging were phone calls (145 clients, 46.8%) and
text messaging (138 clients, 44.5%). The preferred schedule for
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receiving such messages were monthly (181 clients, 57.1%), fortnightly
(123 clients, 38.8%), or daily (13 clients, 4.1%). Overall, 125 clients
(39.4%) indicated they would consider unsolicited sending of such
messages to be an invasion of their privacy. This included 107 of the
125 (ie, 40.5%) clients who agreed to receive the messages.
In bivariate analysis, the sociodemographic characteristics of
clients that were associated with acceptance or rejection of NCD
m‐Health messages were male sex (OR = 0.44; 95% CI, 0.23‐0.86;
P value < 0.01), aged 31 to 50 years (OR = 0.18; 95% CI, 0.08‐
0.42, P value < 0.01), Christian religion (OR = 0.14; 95% CI, 0.02‐
1.12; P value = 0.04), and educational level beyond JHS (OR = 3.19;
95% CI, 1.38‐7.37; P value < 0.01). Compared with single women,
those who were married were less likely to accept m‐Health
messages (OR = 0.45; 95% CI, 0.22‐0.92; P value = 0.03) (Table 1).
Clients who were aware that obesity was a risk factor for NCD
(OR = 0.40; 95% CI, 0.17‐0.93; P value = 0.03), those whose most
recent BP check was more than 12 months ago (OR = 0.43; 95%
CI, 0.20‐0.93; P value = 0.03), and those who had a family history
of diabetes (OR = 0.33; 95% CI, 0.14‐0.79; P value = 0.03) were also
less likely to accept NCD m‐Health (Table 2). In multivariate analysis
using logistic regression, the variables that were associated with
rejection of NCD m‐Health included being male (OR = 0.39; 95%
CI, 0.18‐0.83), being aged 31 to 50 years (OR = 0.22; 95% CI,
0.07‐0.61), and knowing obesity to be a risk factor for NCD
(OR = 0.32; 95% CI, 0.13‐0.79). In contrast, being educated beyond
junior high school (OR = 4.77; 95% CI, 1.72‐13.18) was a predictor
of the acceptability of NCD m‐Health. The multivariate model was
significant at a P value of <0.01 (Tables 1 and 2).
4 | DISCUSSION
We have used a cross‐sectional study to assess CP clients' knowledge
of the risk factors for NCDs, willingness to be screened for NCDs, and
willingness to be enrolled in an NCD m‐Health program. The
sociodemographic characteristics of the sample surveyed is similar to
that of the general population in the two districts, as established in
the 2010 National Population and Housing Census.28 The higher pro-
portion of males reflect the census finding of a higher male‐to‐female
ratio in the urban areas of these districts. Characteristics such as age,
marital status, ethnicity, and educational level generally coincide with
the findings of the census.
Current estimates suggest that between 30% and 40% of the
adult population in Ghana have high BP, and out of this proportion,
about 30% to 40% are unaware of it.29-32 In this study, we found that
a high proportion of pharmacy clients (including high‐risk individuals)
had neither checked their weight nor BP for over 12 months. The find-
ing is consistent with other studies in Ghana and countries in the sub-
region. They help to explain why complications such as stroke have
become the unfortunate events through which uncontrolled BP often
gets to be diagnosed.9,33,34 The findings of this study make a case for
increased access to NCD screening in this population. A policy‐guided
TABLE 1 Bivariate analysis to determine how respondents' sociodemographic background predict agreement to receive NCD m‐Health
promotional mobile phone messages
Variable n
Agree to Receive NCD
m‐Health Messages Unadjusted
Adjusted Odds
Ratio (95% CI)Yes No Odds Ratio (95% CI) P value
Sex Male 183 (57.7) 141 (88.9) 40 (22.1) 0.44 (0.23‐0.86) 0.01 0.39 (0.18‐0.83)
Female 134 (42.3) 112 (88.9) 14 (11.1) 1.00 1.00
Age, y >50 39 (11.8) 33 (84.6) 6 (15.4) 0.36 (0.12‐1.13) <0.01 0.39 (0.09‐1.62)
31‐50 158 (47.8) 111 (73.5) 40 (26.5) 0.18 (0.08‐0.42) 0.22 (0.07‐0.61)
≤30 133 (40.3) 122 (93.9) 8 (6.2) 1.00 1.00
Religiona Christian 292 (89.9) 232 (82.0) 51 (18.0) 0.14 (0.02‐1.12) 0.04 NA
Non‐Christian 33 (10.2) 31 (96.9) 1 (3.1) 1.00
Ethnicityab Ga‐Adangbe 160 (49.5) 129 (82.7) 27 (17.3) 0.57 (0.16‐2.04) 0.79 NA
Ewe 65 (20.1) 50 (80.7) 12 (19.4) 0.50 (0.13‐1.97)
Akan 68 (21.1) 55 (82.1) 12 (17.9) 0.55 (0.14‐2.15)
Other 30 (9.3) 25 (89.3) 3 (10.7) 1.00
Marital status Married 148 (44.9) 116 (80.1) 28 (19.4) 0.45 (0.22‐0.92) 0.03 1.47 (0.56‐3.88)
Divorced/separated/
widowed
48 (14.6) 34 (72.3) 13 (27.7) 0.29 (0.12‐0.69) <0.01 0.65 (0.20‐2.13)
Single 13 (40.6) 119 (90.2) 13 (9.9) 1.00 1.00
Highest educational level SHS/graduate 169 (51.2) 147 (90.7) 15 (9.3) 3.19 (1.38‐7.37) <0.01 4.77 (1.72‐13.18)
Primary/JHS 107 (32.4) 79 (75.2) 26 (24.8) 0.99 (0.46‐2.13) 1.70 (0.69‐4.15)
None 54 (16.4) 40 (75.5) 13 (24.5) 1.00 1.00
Walking distance: Residence
to pharmacy, min
>60 181 (55.5) 153 (86.9) 23 (13.1) 1.29 (0.51‐3.26) 0.08 NA
30‐60 102 (31.3) 74 (76.3) 23 (23.7) 0.63 (0.24‐1.60)
<30 43 (13.2) 36 (83.7) 7 (16.3) 1.00
Employment status Unemployed 62 (22.6) 51 (83.6) 10 (16.4) 0.91 (0.42‐1.99) 0.82 NA
Employed 212 (77.4) 173 (84.8) 31 (15.2) 1.00
Abbreviations: CI, confidence interval; JHS, junior high school; NA, not applicable; NCD, noncommunicable disease.
aExcluded from the multivariate model because of small numbers
bFisher exact estimates of P values. Multivariate model was significant at the P value of <0.01.
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introduction of NCD screening in CPs in Ghana will be an important
addition to PHC.
In this study, we found that there is very little awareness of the
fact that family history is a risk factor for hypertension and diabetes.
Family history is among the strongest risk factors for the development
of hypertension and diabetes.35,36 A population‐based survey among
5389 adults inThe Gambia found that a significant number of subjects
with a family history of hypertension had a higher diastolic BP, body
mass index, higher cholesterol, and uric acid concentrations than those
without such family history.37 The fact that family history is a risk fac-
tor for most NCDs needs to be emphasized through public education.
Given the fact that about half (50.6%) of respondents were educated
beyond the Junior High School level, the finding that only 32.8% of
respondents knew family history to be a risk factor for NCD is worry-
ing. Besides access to services, this could be another important reason
why 57.5% and 71.3% of respondents with a family history of hyper-
tension had not had their weight and BP checked for over 12 months,
respectively. Another risk factor that did not appear to have a bearing
on the health‐seeking behavior of respondents was age. There is the
need to integrate education on the risk factors for NCDs into school
curricula as part of the national response to the challenge posed by
NCDs. Information on how age and family history are linked to the risk
of NCD should be made a standard part of NCD screening in CPs and
over‐the‐counter–medicine shops.
Overall, the findings made in respect of current health‐seeking
behavior contrast with the overwhelming support for the idea to intro-
duce NCD screening into CPs. This suggest respondents had an inher-
ent appreciation of the value of NCD screening and look forward to
the opportunity to get screened. However, the fact that those who
declined to participate in the survey cited time as a constraint is
important. This is because when actual screening comes to be intro-
duced, clients will be required to spend even more time at the CP.
Among clients who decline to be screened due to time constraints,
there may be a high proportion of those who are hard pressed for
time, likelier to be under stress and, therefore, at greater risk of being
hypertensive. This is likely to reduce the number of clients who will be
found during screening to have hypertension or to be at risk of devel-
oping it. Serious consideration needs to be given to reducing to the
barest minimum the additional time clients will spend in CPs to get
screened for NCDs.
Over the many years that the health systems in LMICs have
focused predominantly on the prevention and treatment of infec-
tious diseases, insufficient attention has been given to NCDs. Pri-
mary health care programs have hardly included basic interventions
like adult screening for NCDs. The fact, therefore, that a sizeable
proportion of clients (including people at high risk) have not had
weight or BP checked for a long time may as much be due to poor
health‐seeking behavior as it may be due to an unreformed PHC
system.
The detection of hypertension in Ghana remains low and
haphazard.23,26,31,38 This translates into a higher incidence of stroke
and other complications of uncontrolled hypertension. A review of
adult admissions at the Komfo Anokye Teaching Hospital, the second
biggest in Ghana, found that stroke constituted 9.1% of total medical
adult admissions and 13.2% of all medical adult deaths39 from January
2006 to December 2007. There is the need for a reform of the PHC
system in the country to take into account primordial, primary, and
secondary NCD prevention.
TABLE 2 Bivariate analysis to determine how knowledge, health‐seeking behavior, and family history predict agreement to receive NCD
m‐Health promotional mobile phone messages
Variable n
Agree to receive NCD
m‐Health Messages Unadjusted
Adjusted Odds
Ratio (95% CI)Yes No Odds Ratio (95% CI) P value
Knowledge of the risk
factors for NCDs
Obesity Yes 245 (74.9) 192 (80.3) 47 (19.7) 0.40 (0.17‐0.93) 0.03 0.32 (0.13‐0.79)
No 81 (24.7) 72 (91.1) 7 (8.9) 1.00 1.00
Family history Yes 88 (27.0) 67 (79.8) 17 (20.2) 0.74 (0.39‐1.41) 0.36 NA
No 238 (73.0) 196 (84.1) 37 (15.9) 1.00
Smoking Yes 266 (81.9) 211 (82.1) 46 (17.9) 0.72 (0.32‐1.62) 0.43 NA
No 59 (18.2) 51 (86.4) 8 (13.6) 1.00
Excess dietary salta Yes 299 (91.7) 240 (83.0) 50 (17.2%) 0.83 (0.28‐2.52) 1.00 NA
No 27 (8.3) 23 (85.2) 4 (14.8) 1.00
Knowing one's weight Yes 112 (35.1) 87 (84.5) 20 (18.7) 0.70 (0.37‐1.32) 0.27 NA
No 207 (64.9) 174 (86.1) 28 (13.9) 1.00
Most recent weight
check
>1 y ago 197 (61.6) 154 (80.6) 37 (19.4) 0.65 (0.34‐1.24) 0.25 NA
≤1 y ago 123 (38.4) 102 (86.4) 16 (13.6) 1.00
Knowing one's BP Yes 67 (20.8) 57 (90.5) 6 (9.5) 2.15 (0.87‐5.33) 0.09 NA
No 255 (79.2) 203 (81.5) 46 (18.5) 1.00
Most recent BP check >12 mo ago 230 (70.6) 179 (80.0) 45 (20.1) 0.43 (0.20‐0.93) 0.03 0.45 (0.20‐1.03)
<12 mo 96 (29.4) 83 (90.2) 9 (9.8) 1.00 1.00
Family history of
hypertension
Yes 82 (25.0) 63 (77.8) 18 (22.2) 0.51 (0.23‐1.14) 0.25 NA
No 142 (43.3) 114 (83.2) 23 (16.8) 0.73 (0.35‐1.53)
Don't know 104 (31.7) 88 (87.1) 13 (12.9) 1.00
Family history of diabetes Yes 44 (13.4) 31 (70.5) 13 (29.6) 0.33 (0.14‐0.79) 0.03 0.69 (0.26‐1.81)
No 158 (48.2) 126 (82.9) 26 (17.1) 0.67 (0.34‐1.34) 0.99 (0.44‐2.21)
Don't know 126 (38.4) 108 (87.8) 15 (12.2) 1.00 1.00
Abbreviations: CI, confidence interval; NA, not applicable; NCD, noncommunicable disease.
aFisher exact estimates of P values. Multivariate model was significant at the P value of <0.01.
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In this study, we found instances that suggest missed opportuni-
ties for NCD counseling, screening, and detection of life‐threatening
situations. Extrapolated across the country and the subregion, it is
conceivable that hundreds of thousands of such missed opportunities
occur daily with deleterious consequences. In Ghana, the industry of
CPs is driven largely by the private sector. While pharmacists and
assistants are professionally enjoined to consider their work in CPs
within the social context, the urge for profit could undermine a com-
mitment to public health and PHC.40 Client expectation that NCD
screening services should either be free or for token is unlikely to
meet with the expectations of CPs. Given the overall public health
good that NCD screening in CPs will serve, there is a case for services
rendered to be reimbursable under the Ghana National Health Insur-
ance Scheme. A rethinking of PHC and a firm, formal integration of
community‐based NCD screening in Ghana and other countries in
SSA is long overdue.41 Community pharmacies can play a key role in
this regard.27
The finding in this study that over 90% of respondents have
access to mobile phones is consistent with reports indicating that
mobile phone voice and data penetration in Ghana stands at 127%
(implies more active phones than the population) and 65%, respec-
tively.42 Particularly striking for this largely rural setting is the fact that
the messaging platform WhatsApp was available to over 50% of
respondents. There is certainly in this population the opportunity to
explore the use of m‐Health resources to promote NCD prevention
and follow‐up on services. The diversity in preferences expressed in
respect of desired frequency of messaging, the forms of messaging,
and the issue of privacy‐invasion point to the fact that the use of
NCD m‐Health resources suggest a need to customize services.
Individual‐level informed consent and flexibility in the options
available to clients needs to be considered.
In this study, we found that clients with little or no education
were less likely to accept NCD m‐Health messages. This is under-
standable given that the ability to read and write is required for clients
to independently understand NCD m‐Health text messages. Our find-
ings are consistent with the recommendation that m‐Health interven-
tions be designed to be easy to use by people with low educational
levels.43 Despite great enthusiasm for NCD m‐Health innovations in
SSA, there is very little routine implementation.44
4.1 | Limitations
Despite some profound findings made in this study, there are impor-
tant limitations that need to inform interpretation of the findings.
The study was limited to six private CPs in the three districts. It is con-
ceivable that location and customer service at selected CPs influenced
attitudes towards the proposed NCD screening. Another important
limitation is the small sample size. The effect of this is particularly
evident in the outputs of the regression analysis where small numbers
in some of the cells undermine the robustness of the established esti-
mates. A follow‐up qualitative exploration of the findings could also
have helped to contextualize some of the findings. Of interest is the
role of sex. In this study, we found that female clients were less likely
to accept NCD m‐Health. The role of sex in the acceptance of
m‐Health needs to be explored as it has been found to greatly
influence health‐seeking behavior in African rural and suburban
settings.45,46 This study was conducted among clients who were
already seeking a health service. A household survey is likely to yield
a less biased group of respondents.
5 | CONCLUSIONS
The knowledge of family history as a risk factor for NCD is low in this
population. There is an urgent need to promote access to screening
for hypertension, especially among individuals who are at high risk
because of age and first‐degree relations who have hypertension.
The prospect for introducing screening for NCDs in CPs appears
acceptable to most clients of CPs. Pilot implementation studies that
incorporate m‐Health and involve LCS as well are needed to facilitate
a learning‐by‐doing approach in the country.
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